Abg-Wtt Global Life Science Capital Partners Gp Ltd
Investment Portfolio & 13F Holdings Analysis
About
ABG-WTT Global Life Science Capital Partners GP Ltd is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 4 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.
AI_NATIVE detailed information: This accession holds the following tickers:[ "CBLL", "LUNG", "RPID", "CGON" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 4
- Total Value
- 38322526
- Accession Number
- 0000950123-25-005578
- Form Type
- 13F-HR
- Manager Name
- Abgwtt-Global-Life-Science-Capital-Partners-Gp
Data Enrichment
100% identified4 identified0 unidentified
Holdings
4 positions
Manager:
Search and click to pin securities to the top
Instrument | Shares | Other Manager | Value | ||
|---|---|---|---|---|---|
Ceribell, Inc.(CBLLcusip15678C102) | 1.1M | QoQ 0.00% (-0)YoY NEW(+1.1M) | All Managers (Combined) | $20.9M | YoY NEW(+$20.9M) |
| 495.5K | All Managers (Combined) | $12.1M | |||
| 1.8M | All Managers (Combined) | $4.9M | |||
Pulmonx Corp(LUNGcusip745848101) | 60.2K | All Managers (Combined) | $405.2K |